These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 15578158

  • 21. Strontium ranelate in osteoporosis.
    Reginster JY.
    Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
    [Abstract] [Full Text] [Related]

  • 22. Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia.
    Seeman E, Devogelaer JP, Lorenc R, Spector T, Brixen K, Balogh A, Stucki G, Reginster JY.
    J Bone Miner Res; 2008 Mar; 23(3):433-8. PubMed ID: 17997711
    [Abstract] [Full Text] [Related]

  • 23. The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women.
    Stevenson M, Davis S, Lloyd-Jones M, Beverley C.
    Health Technol Assess; 2007 Feb; 11(4):1-134. PubMed ID: 17280622
    [Abstract] [Full Text] [Related]

  • 24. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age.
    Seeman E, Boonen S, Borgström F, Vellas B, Aquino JP, Semler J, Benhamou CL, Kaufman JM, Reginster JY.
    Bone; 2010 Apr; 46(4):1038-42. PubMed ID: 20026265
    [Abstract] [Full Text] [Related]

  • 25. Osteoporosis: from early fracture prevention to better bone health with strontium ranelate.
    Cortet B.
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv14-9. PubMed ID: 19783589
    [Abstract] [Full Text] [Related]

  • 26. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years.
    Reginster JY, Bruyère O, Sawicki A, Roces-Varela A, Fardellone P, Roberts A, Devogelaer JP.
    Bone; 2009 Dec; 45(6):1059-64. PubMed ID: 19679207
    [Abstract] [Full Text] [Related]

  • 27. Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older.
    Seeman E, Vellas B, Benhamou C, Aquino JP, Semler J, Kaufman JM, Hoszowski K, Varela AR, Fiore C, Brixen K, Reginster JY, Boonen S.
    J Bone Miner Res; 2006 Jul; 21(7):1113-20. PubMed ID: 16813532
    [Abstract] [Full Text] [Related]

  • 28. Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis.
    Roux C, Fechtenbaum J, Kolta S, Isaia G, Andia JB, Devogelaer JP.
    Ann Rheum Dis; 2008 Dec; 67(12):1736-8. PubMed ID: 18713788
    [Abstract] [Full Text] [Related]

  • 29. Prospective assessment of thoracic kyphosis in postmenopausal women with osteoporosis.
    Roux C, Fechtenbaum J, Kolta S, Said-Nahal R, Briot K, Benhamou CL.
    J Bone Miner Res; 2010 Feb; 25(2):362-8. PubMed ID: 19594302
    [Abstract] [Full Text] [Related]

  • 30. A new treatment for post-menopausal osteoporosis: strontium ranelate.
    Rizzoli R.
    J Endocrinol Invest; 2005 Feb; 28(8 Suppl):50-7. PubMed ID: 16323829
    [Abstract] [Full Text] [Related]

  • 31. Strontium ranelate in the prevention of osteoporotic fractures.
    Reginster JY, Malaise O, Neuprez A, Bruyere O.
    Int J Clin Pract; 2007 Feb; 61(2):324-8. PubMed ID: 17263720
    [Abstract] [Full Text] [Related]

  • 32. Continuous broad protection against osteoporotic fractures with strontium ranelate.
    Ferrari S.
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv20-4. PubMed ID: 19783590
    [Abstract] [Full Text] [Related]

  • 33. Strontium ranelate for the management of osteoporosis.
    Lam S, Zouzias K.
    Consult Pharm; 2008 Jul; 23(7):531-7. PubMed ID: 18764671
    [Abstract] [Full Text] [Related]

  • 34. Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover.
    Collette J, Bruyère O, Kaufman JM, Lorenc R, Felsenberg D, Spector TD, Diaz-Curiel M, Boonen S, Reginster JY.
    Osteoporos Int; 2010 Feb; 21(2):233-41. PubMed ID: 19436941
    [Abstract] [Full Text] [Related]

  • 35. Strontium ranelate: short- and long-term benefits for post-menopausal women with osteoporosis.
    Roux C.
    Rheumatology (Oxford); 2008 Jul; 47 Suppl 4(Suppl 4):iv20-22. PubMed ID: 18556647
    [Abstract] [Full Text] [Related]

  • 36. Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis.
    Deeks ED, Dhillon S.
    Drugs; 2010 Apr 16; 70(6):733-59. PubMed ID: 20394457
    [Abstract] [Full Text] [Related]

  • 37. A review of strontium ranelate and its effect on DXA scans.
    Blake GM, Lewiecki EM, Kendler DL, Fogelman I.
    J Clin Densitom; 2007 Apr 16; 10(2):113-9. PubMed ID: 17485027
    [Abstract] [Full Text] [Related]

  • 38. Strontium ranelate: a novel mode of action optimizing bone formation and resorption.
    Marie PJ.
    Osteoporos Int; 2005 Jan 16; 16 Suppl 1():S7-10. PubMed ID: 15578159
    [Abstract] [Full Text] [Related]

  • 39. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
    Neuprez A, Hiligsmann M, Scholtissen S, Bruyere O, Reginster JY.
    Adv Ther; 2008 Dec 16; 25(12):1235-56. PubMed ID: 19066755
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.